Custodiol versus blood cardioplegia in complex cardiac operations: an Australian experience | Zendy

Fabiano Viana | Zendy; William Y. Shi | Zendy; Philip Hayward | Zendy; Marco Larobina | Zendy; Frank Liskaser | Zendy; George Matalanis | Zendy

AI Assistant Blog Pricing

Open Access

Custodiol versus blood cardioplegia in complex cardiac operations: an Australian experience

Author(s) -

Fabiano Viana,

William Y. Shi,

Philip Hayward,

Marco Larobina,

Frank Liskaser,

George Matalanis

Publication year - 2012

Publication title -

european journal of cardio-thoracic surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.303

H-Index - 133

eISSN - 1873-734X

pISSN - 1010-7940

DOI - 10.1093/ejcts/ezs319

Subject(s) - medicine , propensity score matching , myocardial infarction , anesthesia , clinical endpoint , cardiopulmonary bypass , cardiology , randomized controlled trial

A single or dual-dose strategy for myocardial protection is attractive in long operations, in avoiding the need to interrupt the procedure to re-administer cardioplegia. We hypothesized that a single administration of Bretschneider histidine-tryptophan-ketoglutarate (HTK) crystalloid solution (Custodiol) offers myocardial protection comparable with repeated tepid blood cardioplegia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog